| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 24 | 2021 | 292 | 1.730 |
Why?
|
| Education, Medical, Graduate | 3 | 2017 | 347 | 0.900 |
Why?
|
| Chronic Pain | 3 | 2022 | 157 | 0.880 |
Why?
|
| Documentation | 1 | 2025 | 135 | 0.860 |
Why?
|
| Virtual Reality | 2 | 2021 | 16 | 0.830 |
Why?
|
| Electronic Health Records | 2 | 2025 | 398 | 0.810 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2014 | 76 | 0.800 |
Why?
|
| Coronary Artery Disease | 9 | 2020 | 326 | 0.800 |
Why?
|
| Personal Satisfaction | 2 | 2014 | 83 | 0.800 |
Why?
|
| Attitude of Health Personnel | 2 | 2025 | 634 | 0.730 |
Why?
|
| Parents | 3 | 2018 | 418 | 0.710 |
Why?
|
| Cystic Fibrosis | 1 | 2022 | 126 | 0.690 |
Why?
|
| Thoracic Surgery | 5 | 2005 | 80 | 0.670 |
Why?
|
| Specialty Boards | 2 | 2017 | 15 | 0.660 |
Why?
|
| Hospitals, Teaching | 2 | 2017 | 105 | 0.640 |
Why?
|
| Nurses, Pediatric | 1 | 2020 | 5 | 0.630 |
Why?
|
| Compassion Fatigue | 1 | 2020 | 14 | 0.620 |
Why?
|
| Computer-Assisted Instruction | 3 | 2005 | 80 | 0.600 |
Why?
|
| Training Support | 2 | 2017 | 20 | 0.580 |
Why?
|
| Child | 12 | 2022 | 4653 | 0.570 |
Why?
|
| Postoperative Complications | 11 | 2020 | 1336 | 0.570 |
Why?
|
| Educational Measurement | 3 | 2016 | 214 | 0.540 |
Why?
|
| Burnout, Professional | 1 | 2020 | 145 | 0.530 |
Why?
|
| Mucopolysaccharidoses | 2 | 2019 | 4 | 0.530 |
Why?
|
| Accreditation | 1 | 2017 | 76 | 0.520 |
Why?
|
| New York | 21 | 2020 | 144 | 0.520 |
Why?
|
| Humans | 67 | 2025 | 65845 | 0.490 |
Why?
|
| Certification | 1 | 2016 | 58 | 0.480 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 92 | 0.470 |
Why?
|
| Financial Management | 1 | 2015 | 6 | 0.460 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 408 | 0.450 |
Why?
|
| Quality of Life | 4 | 2022 | 1266 | 0.440 |
Why?
|
| Registries | 13 | 2020 | 935 | 0.430 |
Why?
|
| Female | 44 | 2025 | 34425 | 0.420 |
Why?
|
| Anxiety | 4 | 2022 | 427 | 0.420 |
Why?
|
| Drug-Eluting Stents | 4 | 2020 | 68 | 0.410 |
Why?
|
| CD-ROM | 2 | 2004 | 4 | 0.410 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2015 | 163 | 0.400 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2020 | 272 | 0.400 |
Why?
|
| Caregivers | 2 | 2014 | 298 | 0.390 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2018 | 171 | 0.390 |
Why?
|
| Internship and Residency | 4 | 2017 | 800 | 0.390 |
Why?
|
| Curriculum | 3 | 2005 | 609 | 0.360 |
Why?
|
| Angioplasty, Balloon, Coronary | 6 | 2012 | 171 | 0.360 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2020 | 226 | 0.360 |
Why?
|
| Internet | 3 | 2005 | 472 | 0.350 |
Why?
|
| Male | 41 | 2022 | 31410 | 0.350 |
Why?
|
| Clinical Competence | 1 | 2016 | 731 | 0.350 |
Why?
|
| Risk Factors | 25 | 2021 | 5475 | 0.340 |
Why?
|
| Adolescent | 10 | 2022 | 6368 | 0.340 |
Why?
|
| Hospital Mortality | 13 | 2021 | 881 | 0.330 |
Why?
|
| Mass Screening | 1 | 2017 | 700 | 0.330 |
Why?
|
| Decision Making | 1 | 2014 | 430 | 0.330 |
Why?
|
| Risk Assessment | 12 | 2020 | 2116 | 0.320 |
Why?
|
| Mitral Valve | 2 | 2018 | 126 | 0.310 |
Why?
|
| Critical Illness | 1 | 2013 | 342 | 0.310 |
Why?
|
| Coronary Disease | 5 | 2013 | 247 | 0.300 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 712 | 0.290 |
Why?
|
| Mental Disorders | 1 | 2017 | 827 | 0.290 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1165 | 0.270 |
Why?
|
| United States | 10 | 2021 | 8189 | 0.270 |
Why?
|
| Time Factors | 16 | 2020 | 3779 | 0.270 |
Why?
|
| Heart Valve Prosthesis | 2 | 2009 | 107 | 0.250 |
Why?
|
| Aortic Valve Stenosis | 3 | 2016 | 190 | 0.250 |
Why?
|
| Physician Executives | 1 | 2005 | 28 | 0.230 |
Why?
|
| Treatment Outcome | 16 | 2023 | 5834 | 0.210 |
Why?
|
| Perception | 1 | 2025 | 187 | 0.210 |
Why?
|
| Funnel Chest | 1 | 2004 | 7 | 0.210 |
Why?
|
| Retrospective Studies | 15 | 2021 | 6957 | 0.210 |
Why?
|
| Surgical Mesh | 1 | 2004 | 60 | 0.210 |
Why?
|
| Child, Preschool | 6 | 2020 | 2090 | 0.200 |
Why?
|
| Aortic Valve | 2 | 2016 | 181 | 0.200 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 71 | 0.200 |
Why?
|
| HIV-1 | 3 | 2007 | 710 | 0.200 |
Why?
|
| Cardiac Catheterization | 3 | 2016 | 293 | 0.200 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2004 | 23 | 0.200 |
Why?
|
| Tricuspid Valve | 1 | 2004 | 28 | 0.200 |
Why?
|
| Enzyme Replacement Therapy | 3 | 2019 | 12 | 0.200 |
Why?
|
| Interviews as Topic | 1 | 2025 | 535 | 0.200 |
Why?
|
| Adenoidectomy | 2 | 2020 | 7 | 0.190 |
Why?
|
| Tonsillectomy | 2 | 2020 | 13 | 0.190 |
Why?
|
| Coronary Vessels | 2 | 2020 | 125 | 0.190 |
Why?
|
| Middle Aged | 27 | 2020 | 18501 | 0.190 |
Why?
|
| Aged | 25 | 2020 | 15147 | 0.190 |
Why?
|
| Biofeedback, Psychology | 1 | 2022 | 6 | 0.180 |
Why?
|
| Hospitalization | 3 | 2019 | 1404 | 0.180 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 81 | 0.180 |
Why?
|
| Guideline Adherence | 2 | 2018 | 310 | 0.180 |
Why?
|
| Patient Readmission | 3 | 2021 | 452 | 0.180 |
Why?
|
| Neonatal Screening | 1 | 2022 | 108 | 0.180 |
Why?
|
| Mortality | 2 | 2020 | 162 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 741 | 0.170 |
Why?
|
| Aged, 80 and over | 16 | 2020 | 5682 | 0.170 |
Why?
|
| Radiography, Thoracic | 1 | 2002 | 117 | 0.170 |
Why?
|
| Medical Marijuana | 1 | 2021 | 9 | 0.170 |
Why?
|
| Technology | 1 | 2021 | 53 | 0.170 |
Why?
|
| Pain Management | 2 | 2021 | 174 | 0.160 |
Why?
|
| Prognosis | 3 | 2022 | 1793 | 0.160 |
Why?
|
| Anesthesiologists | 1 | 2020 | 18 | 0.160 |
Why?
|
| Infant, Newborn | 2 | 2022 | 1439 | 0.160 |
Why?
|
| Heart Rate | 1 | 2022 | 335 | 0.160 |
Why?
|
| Lung Diseases | 1 | 2002 | 183 | 0.160 |
Why?
|
| Cannabis | 1 | 2021 | 54 | 0.160 |
Why?
|
| Patient Handoff | 1 | 2020 | 36 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 216 | 0.150 |
Why?
|
| Child Behavior | 1 | 2020 | 67 | 0.150 |
Why?
|
| Chondroitinsulfatases | 1 | 2019 | 1 | 0.150 |
Why?
|
| Mucopolysaccharidosis IV | 1 | 2019 | 1 | 0.150 |
Why?
|
| Reoperation | 2 | 2019 | 307 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1719 | 0.150 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 2790 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 201 | 0.150 |
Why?
|
| Ventricular Dysfunction | 1 | 2019 | 14 | 0.150 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2010 | 5 | 0.150 |
Why?
|
| Forecasting | 2 | 2017 | 231 | 0.140 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 2500 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2021 | 593 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2022 | 1030 | 0.140 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2018 | 17 | 0.140 |
Why?
|
| Analgesics | 1 | 2019 | 102 | 0.140 |
Why?
|
| Intensive Care Units | 2 | 2020 | 437 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2018 | 47 | 0.140 |
Why?
|
| Pain | 2 | 2021 | 400 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 101 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2012 | 312 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2018 | 89 | 0.130 |
Why?
|
| Capital Financing | 1 | 2017 | 5 | 0.130 |
Why?
|
| Communication Barriers | 1 | 2018 | 71 | 0.130 |
Why?
|
| Organizational Objectives | 1 | 2017 | 61 | 0.130 |
Why?
|
| Heart Failure | 2 | 2019 | 968 | 0.130 |
Why?
|
| Disease Management | 1 | 2019 | 235 | 0.130 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2018 | 98 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 121 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2019 | 223 | 0.130 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2007 | 123 | 0.130 |
Why?
|
| Advisory Committees | 1 | 2017 | 111 | 0.130 |
Why?
|
| American Medical Association | 1 | 2016 | 5 | 0.130 |
Why?
|
| Adult | 9 | 2020 | 17579 | 0.120 |
Why?
|
| Domestic Violence | 1 | 2017 | 40 | 0.120 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 284 | 0.120 |
Why?
|
| Universities | 1 | 2017 | 169 | 0.120 |
Why?
|
| Pediatricians | 1 | 2017 | 63 | 0.120 |
Why?
|
| Fatigue | 1 | 2016 | 114 | 0.110 |
Why?
|
| Medically Underserved Area | 1 | 2015 | 31 | 0.110 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 442 | 0.110 |
Why?
|
| HIV Infections | 1 | 2002 | 961 | 0.110 |
Why?
|
| Proportional Hazards Models | 6 | 2016 | 746 | 0.110 |
Why?
|
| Stents | 2 | 2011 | 500 | 0.110 |
Why?
|
| Medicare | 2 | 2017 | 629 | 0.110 |
Why?
|
| Sternum | 2 | 2004 | 29 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2015 | 153 | 0.100 |
Why?
|
| Cerebrum | 1 | 2014 | 16 | 0.100 |
Why?
|
| Myocardial Infarction | 2 | 2019 | 922 | 0.100 |
Why?
|
| Angina Pectoris | 1 | 2013 | 35 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 220 | 0.100 |
Why?
|
| Young Adult | 3 | 2021 | 4883 | 0.100 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 65 | 0.100 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2015 | 110 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2007 | 424 | 0.100 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2010 | 59 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2014 | 224 | 0.090 |
Why?
|
| Health Surveys | 1 | 2013 | 319 | 0.090 |
Why?
|
| Exercise Test | 1 | 2013 | 257 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2016 | 473 | 0.090 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2012 | 19 | 0.090 |
Why?
|
| Survival Rate | 5 | 2015 | 849 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 94 | 0.090 |
Why?
|
| Psychometrics | 1 | 2013 | 396 | 0.080 |
Why?
|
| Medicaid | 1 | 2015 | 379 | 0.080 |
Why?
|
| Workload | 2 | 2018 | 132 | 0.080 |
Why?
|
| Hospitals | 2 | 2004 | 399 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2017 | 289 | 0.080 |
Why?
|
| Hematocrit | 1 | 2010 | 32 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2014 | 535 | 0.080 |
Why?
|
| Myocardial Revascularization | 2 | 2008 | 78 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2007 | 91 | 0.080 |
Why?
|
| Stroke | 1 | 2019 | 1225 | 0.080 |
Why?
|
| Hypothermia | 1 | 2010 | 15 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 126 | 0.080 |
Why?
|
| Fever | 1 | 2010 | 67 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 2 | 2011 | 349 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 413 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 758 | 0.070 |
Why?
|
| Logistic Models | 5 | 2016 | 1274 | 0.070 |
Why?
|
| Macrophages, Alveolar | 2 | 2007 | 65 | 0.070 |
Why?
|
| Heart Valves | 1 | 2007 | 26 | 0.060 |
Why?
|
| Clinical Decision-Making | 2 | 2018 | 170 | 0.060 |
Why?
|
| Virus Replication | 2 | 2007 | 323 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2007 | 129 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 84 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 1569 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2013 | 3340 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 248 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2019 | 130 | 0.060 |
Why?
|
| Chemokines, CX3C | 1 | 2004 | 3 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2004 | 12 | 0.050 |
Why?
|
| Osteotomy | 1 | 2004 | 20 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 30 | 0.050 |
Why?
|
| Cartilage | 1 | 2004 | 35 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 2324 | 0.050 |
Why?
|
| California | 2 | 2020 | 178 | 0.050 |
Why?
|
| Infant | 2 | 2019 | 1718 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2004 | 97 | 0.050 |
Why?
|
| Referral and Consultation | 2 | 2004 | 447 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2005 | 202 | 0.050 |
Why?
|
| Risk Adjustment | 2 | 2019 | 94 | 0.050 |
Why?
|
| Propensity Score | 2 | 2016 | 192 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2012 | 579 | 0.050 |
Why?
|
| Software Design | 1 | 2002 | 28 | 0.050 |
Why?
|
| Prevalence | 2 | 2020 | 1454 | 0.050 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2002 | 38 | 0.040 |
Why?
|
| Aneurysm, Infected | 1 | 2002 | 13 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2002 | 67 | 0.040 |
Why?
|
| Los Angeles | 1 | 2021 | 14 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2012 | 888 | 0.040 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2002 | 109 | 0.040 |
Why?
|
| Retreatment | 1 | 2020 | 43 | 0.040 |
Why?
|
| Length of Stay | 1 | 2004 | 828 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2011 | 757 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1226 | 0.040 |
Why?
|
| Colorado | 1 | 2020 | 21 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 56 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 1117 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 375 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2020 | 212 | 0.040 |
Why?
|
| Mucopolysaccharidosis VI | 1 | 2019 | 1 | 0.040 |
Why?
|
| N-Acetylgalactosamine-4-Sulfatase | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hypercapnia | 1 | 2019 | 14 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 806 | 0.040 |
Why?
|
| Hypnosis, Anesthetic | 1 | 2018 | 1 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 298 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 195 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2018 | 67 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2002 | 314 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 294 | 0.030 |
Why?
|
| Incidence | 2 | 2015 | 1433 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 710 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 107 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 293 | 0.030 |
Why?
|
| Coronary Restenosis | 2 | 2008 | 21 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2017 | 65 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2018 | 346 | 0.030 |
Why?
|
| Palliative Care | 1 | 2019 | 251 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1294 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 357 | 0.030 |
Why?
|
| Surgeons | 1 | 2018 | 191 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 484 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2002 | 712 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 237 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 252 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2015 | 210 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 2014 | 34 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 142 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 52 | 0.020 |
Why?
|
| Thalamus | 1 | 2014 | 78 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 129 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 995 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 420 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2010 | 47 | 0.020 |
Why?
|
| American Heart Association | 1 | 2010 | 130 | 0.020 |
Why?
|
| Observation | 1 | 2008 | 30 | 0.020 |
Why?
|
| Cardiology | 1 | 2010 | 172 | 0.020 |
Why?
|
| Time | 1 | 2007 | 30 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2007 | 65 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2007 | 17 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2007 | 232 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 1503 | 0.010 |
Why?
|
| Surgery Department, Hospital | 1 | 2004 | 19 | 0.010 |
Why?
|
| Receptors, CCR4 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 856 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2004 | 29 | 0.010 |
Why?
|
| Utilization Review | 1 | 2003 | 32 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 344 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 965 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 377 | 0.010 |
Why?
|
| Health Services Research | 1 | 2003 | 265 | 0.010 |
Why?
|
| Aortic Rupture | 1 | 2002 | 47 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 1590 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1980 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1148 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2194 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 1573 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 2675 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1583 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1635 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 1663 | 0.010 |
Why?
|